By Juby Babu, Max A. Cherney and Stephen Nellis Feb 4 (Reuters) - Shares of Arm Holdings fell on Wednesday as its licensing ...

The CEO’s job isn’t to manage every stage of the funnel. It’s to design and protect the loop that allows insight to move ...

Electronic Arts Inc (NASDAQ:EA, XETRA:ERT) reported a surge in sales in its third fiscal quarter, driven by the blockbuster ...

The rivalry in the GLP-1 market between pharmaceutical leaders Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) has ...

Several bills introduced this session would partially or fully exempt schools from paying the expanded sales tax, but it's ...

By Mrinalika Roy and Mariam Sunny Feb 4 (Reuters) - Eli Lilly forecast strong profit growth for 2026 on Wednesday on the back ...

Q1 2026 Management View Dale Asplund, President, CEO & Director, stated BrightView "had a strong start to 2026, as we grew total revenue 3% and delivered improvements in EBITDA while accelerating ...

The rally in Lilly also pressured shares of its main weight-loss rival, Danish drugmaker Novo Nordisk ( NVO ), for a second ...

Clarke summarized that full-year 2025 revenue reached "$4.5 billion, that's up 14%. Cash EPS of $21.38, up 12%. Organic revenue growth for the full year, 10%." He credited acquisitions—especially ...

Here are some of the stocks making the biggest moves in extended trading. Qualcomm — Shares of the chipmaker tanked more than ...

Eli Lilly beat profit estimates and issued strong guidance as demand for its weight-loss drugs surged, even as pricing ...

AI chipmaker Qualcomm (QCOM) reported fiscal first quarter adjusted earnings of $3.50 per share compared to an estimate of $3 ...